Monitoring nanoparticle-mediated cellular hyperthermia with a high-sensitivity biosensor

Nanomedicine

Volumn 9, Issue 18, 2014, Pages 2729-2743

  Mukherjee, Amarnath ^a   Castanares, Mark ^a,b   Hedayati, Mohammad ^a   Wabler, Michele ^a   Trock, Bruce ^a   Kulkarni, Prakash ^a   Rodriguez, Ronald ^a,c   Getzenberg, Robert H ^a,d   Deweese, Theodore L ^a   Ivkov, Robert ^a   Lupold, Shawn E ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d GTx Inc   (United States)

Author keywords

heat shock; hyperthermia; iron oxide nanoparticle; Metridia luciferase; nanoparticle

Indexed keywords

IRON OXIDE NANOPARTICLE; LUCIFERASE; METAL NANOPARTICLE; NANOPARTICLE; UNCLASSIFIED DRUG; FERRIC ION; FERRIC OXIDE; HEAT SHOCK PROTEIN 70; MAGNETITE NANOPARTICLE;

ARTICLE; BATH; BIOSENSOR; CELLULAR IMMUNITY; CONTROLLED STUDY; CORRELATION ANALYSIS; HCT116 CELL LINE; HEAT TOLERANCE; HEAT TRANSFER; HEATING; HUMAN; HUMAN CELL; HYPERTHERMIA; LUCIFERASE ASSAY; MAGNETIC FIELD; MEDIATOR; REPORTER GENE; TEMPERATURE MEASUREMENT; TEMPERATURE STRESS; CHEMISTRY; DEVICES; EQUIPMENT DESIGN; GENETIC PROCEDURES; GENETICS; HYPERTHERMIC THERAPY; LUMINESCENCE; NEOPLASMS; PROCEDURES; TUMOR CELL LINE;

BIOSENSING TECHNIQUES; CELL LINE, TUMOR; EQUIPMENT DESIGN; FERRIC COMPOUNDS; GENES, REPORTER; HEATING; HSP70 HEAT-SHOCK PROTEINS; HUMANS; HYPERTHERMIA, INDUCED; LUCIFERASES; LUMINESCENT MEASUREMENTS; MAGNETIC FIELDS; MAGNETITE NANOPARTICLES; NEOPLASMS;

EID: 84920081559     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.13.207     Document Type: Article

References (38)

1. Ahmed N, Fessi H, Elaissari A. Theranostic applications of nanoparticles in cancer. Drug Discov. Today 17, 928-934 (2012).
2. Chatterjee DK, Diagaradjane P, Krishnan S. Nanoparticle-mediated hyperthermia in cancer therapy. Ther. Deliv. 2(8), 1001-1014 (2011).
3. Nielsen OS, Horsman M, Overgaard J. A future for hyperthermia in cancer treatment?. Eur. J. Cancer 37(13), 1587-1589 (2001).
4. Gordon RT, Hines JR, Gordon D. Intracellular hyperthermia. A biophysical approach to cancer treatment via intracellular temperature and biophysical alterations. Med. Hypotheses 5(1), 83-102 (1979).
5. Basel MT, Balivada S, Wang H et al. Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer model. Int. J. Nanomedicine 7, 297-306 (2012).
6. Giustini AJ, Ivkov R, Hoopes PJ. Magnetic nanoparticle biodistribution following intratumoral administration. Nanotechnology 22(34), 345101 (2011).
7. Johannsen M, Gneveckow U, Thiesen B et al. Thermotherapy of prostate cancer using magnetic nanoparticles: Feasibility, imaging, and three-dimensional temperature distribution. Eur. Urol. 52(6), 1653-1661 (2007).
8. Maier-Hauff K, Ulrich F, Nestler D et al. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J. Neurooncol. 103(2), 317-324 (2011).
9. Dewey WC. Arrhenius relationships from the molecule and cell to the clinic. Int. J. Hyperthermia 25(1), 3-20 (2009).
10. Kariya A, Tabuchi Y, Yunoki T, Kondo T. Identification of common gene networks responsive to mild hyperthermia in human cancer cells. Int. J. Mol. Med. 32(1), 195-202 (2013).
11. Roti Roti JL. Cellular responses to hyperthermia (40-46C): Cell killing and molecular events. Int. J. Hyperthermia 24(1), 3-15 (2008).
12. Krawczyk PM, Eppink B, Essers J et al. Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly(ADP-ribose) polymerase-1 inhibition. Proc. Natl Acad. Sci. USA 108(24), 9851-9856 (2011).
13. Creixell M, Bohorquez AC, Torres-Lugo M, Rinaldi C. EGFR-Targeted magnetic nanoparticle heaters kill cancer cells without a perceptible temperature rise. ACS Nano 5(9), 7124-7129 (2011).
14. Asin L, Ibarra MR, Tres A, Goya GF. Controlled cell death by magnetic hyperthermia: Effects of exposure time, field amplitude, and nanoparticle concentration. Pharm. Res. 29(5), 1319-1327 (2012).
15. Villanueva A, De La Presa P, Alonso JM et al. Hyperthermia HeLa cell Treatment with silica-coated manganese oxide nanoparticles. J. Phys. Chem. C 114(5), 1976-1981 (2010).
16. Krpetic Z, Nativo P, See V, Prior IA, Brust M, Volk M Inflicting Controlled Nonthermal Damage to Subcellular Structures by Laser-Activated Gold Nanoparticles. Nano Lett. 10(11), 4549-4554 (2010).
17. Jordan A, Scholz R, Wust P et al. Endocytosis of dextran and silan-coated magnetite nanoparticles and the effect of intracellular hyperthermia on human mammary carcinoma cells in vitro. J. Magnet. Magn. Mater. 194(1-3), 185-196 (1999).
18. Rodriguez-Luccioni HL, Latorre-Esteves M, Mendez-Vega J et al. Enhanced reduction in cell viability by hyperthermia induced by magnetic nanoparticles. Int. J. Nanomedicine 6, 373-380 (2011).
19. Gota C, Okabe K, Funatsu T, Harada Y, Uchiyama S. Hydrophilic fluorescent nanogel thermometer for intracellular thermometry. J. Am. Chem. Soc. 131(8), 2766-2767 (2009).
20. Huang H, Delikanli S, Zeng H, Ferkey DM, Pralle A. Remote control of ion channels and neurons through magnetic-field heating of nanoparticles. Nat. Nanotechnol. 5(8), 602-606 (2010).
21. Yang JM, Yang H, Lin L. Quantum dot nano thermometers reveal heterogeneous local thermogenesis in living cells. ACS Nano 5(6), 5067-5071 (2011).
22. Raoof M, Zhu C, Kaluarachchi WD, Curley SA. Luciferase-based protein denaturation assay for quantification of radiofrequency field-induced targeted hyperthermia: Developing an intracellular thermometer. Int. J. Hyperthermia 28(3), 202-209 (2012).
23. Deckers R, Debeissat C, Fortin PY, Moonen CT, Couillaud F. Arrhenius analysis of the relationship between hyperthermia and Hsp70 promoter activation: A comparison between ex vivo and in vivo data. Int. J. Hyperthermia 28(5), 441-450 (2012).
24. Lupold SE, Johnson T, Chowdhury WH, Rodriguez R. A real time Metridia luciferase based non-invasive reporter assay of mammalian cell viability and cytotoxicity via the beta-Actin promoter and enhancer. PLoS ONE 7(5), e36535 (2012).
25. Pelham HR. A regulatory upstream promoter element in the Drosophila hsp70 heat-shock gene. Cell 30(2), 517-528 (1982).
26. Wu BJ, Kingston RE, Morimoto RI. Human HSP70 promoter contains at least two distinct regulatory domains. Proc. Natl Acad. Sci. USA 83(3), 629-633 (1986).
27. Hedayati M, Thomas O, Abubaker-Sharif B et al. The effect of cell-cluster size on intracellular nanoparticle-mediated hyperthermia: Is it possible to treat microscopic tumors?. Nanomedicine (Lond.) 8, 29-41 (2012).
28. Bordelon DE, Cornejo C, Gruettner C, Westphal F, Deweese TL, Ivkov R. Magnetic nanoparticle heating efficiency reveals magneto-structural differences when characterized with wide ranging and high amplitude alternating magnetic fields. J. Appl. Phys. 109(12), 124904 (2011).
29. Joinpoint Regression Program. http://surveillance.cancer.gov/joinpoint
30. Di YP, Repasky EA, Subjeck JR. Distribution of HSP70, protein kinase C, and spectrin is altered in lymphocytes during a fever-like hyperthermia exposure. J. Cell Physiol. 172(1), 44-54 (1997).
31. Park HG, Han SI, Oh SY, Kang HS. Cellular responses to mild heat stress. Cell. Mol. Life Sci. 62(1), 10-23 (2005).
32. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat. Med. 19(3), 335-351 (2000).
33. Field SB, Morris CC. The relationship between heating time and temperature: Its relevance to clinical hyperthermia. Radiother. Oncol. 1(2), 179-186 (1983).
34. Overgaard J, Suit HD. Time-Temperature relationship th hyperthermic treatment of malignant and normal tissue in vivo. Cancer Res. 39(8), 3248-3253 (1979).
35. Gruettner C, Mueller K, Teller J, Westphal F, Foreman A, Ivkov R. Synthesis and antibody conjugation of magnetic nanoparticles with improved specific power absorption rates for alternating magnetic field cancer therapy. J. Magnet. Magn. Mater. 311(1), 181-186 (2007).
36. Klein S, Sommer A, Distel LV, Neuhuber W, Kryschi C. Superparamagnetic iron oxide nanoparticles as radiosensitizer via enhanced reactive oxygen species formation. Biochem. Biophys. Res. Commun. 425(2), 393-397 (2012).
37. Voinov MA, Sosa Pagan JO, Morrison E, Smirnova TI, Smirnov AIi. Surface-mediated production of hydroxyl radicals as a mechanism of iron oxide nanoparticle biotoxicity. J. Am. Chem. Soc. 133(1), 35-41 (2011).
38. Asin L, Goya GF, Tres A, Ibarra MR. Induced cell toxicity originates dendritic cell death following magnetic hyperthermia treatment. Cell Death Dis. 4, e596 (2013).